Thioredoxin-Interacting Protein shows a positive correlation with immune cell infiltration in SCLC, possibly serving as a biomarker for prognosticating treatment outcomes of chemotherapy and immunotherapy in SCLC patients. This evidence concerns the gene TXNIP and small cell lung carcinoma.